Herzer K - Search Results

1

Herzer K, Paul A, Gerken G. Herzer K, et al. Dtsch Med Wochenschr. 2013 Jul;138(28-29):1471-7. doi: 10.1055/s-0033-1343302. Epub 2013 Jul 2. Dtsch Med Wochenschr. 2013. PMID: 23821451 Review. German. No abstract available.

2

[HCV reinfection after liver transplantation - management and first experiences with telaprevir-based triple therapy].

Herzer K, Papadopoulos-Köhn A, Timm J, Paul A, Jochum C, Gerken G. Herzer K, et al. Dtsch Med Wochenschr. 2013 Sep;138(36):1759-64. doi: 10.1055/s-0033-1349494. Epub 2013 Sep 3. Dtsch Med Wochenschr. 2013. PMID: 24002874 German.

3

Diagnostics and treatment of a severe humoral rejection after liver transplantation: donor-specific antibodies as a still underestimated cause of graft failure.

Rashidi-Alavijeh J, Heinold A, Willuweit K, Baba HA, Horn PA, Paul A, Witzke O, Gerken G, Herzer K. Rashidi-Alavijeh J, et al. Among authors: herzer k. Z Gastroenterol. 2016 Jul;54(7):647-52. doi: 10.1055/s-0042-108212. Epub 2016 Jul 18. Z Gastroenterol. 2016. PMID: 27429102 English.

4

Glutamate dehydrogenase and alkaline phosphatase as very early predictors of hepatocellular carcinoma recurrence after liver transplantation.

Piras-Straub K, Khairzada K, Gerken G, Saner F, Treckmann J, Paul A, Canbay A, Herzer K. Piras-Straub K, et al. Among authors: herzer k. Digestion. 2015;91(2):117-27. doi: 10.1159/000370212. Epub 2015 Jan 30. Digestion. 2015. PMID: 25662469

5

Daclatasvir, Simeprevir and Ribavirin as a Promising Interferon-Free Triple Regimen for HCV Recurrence after Liver Transplant.

Herzer K, Papadopoulos-Köhn A, Walker A, Achterfeld A, Paul A, Canbay A, Timm J, Gerken G. Herzer K, et al. Digestion. 2015;91(4):326-33. doi: 10.1159/000382075. Epub 2015 May 19. Digestion. 2015. PMID: 25999053

6

When and How to Treat HCV Infection with the New Antivirals before or after Liver Transplantation.

Herzer K, Gerken G. Herzer K, et al. Visc Med. 2016 Aug;32(4):258-262. doi: 10.1159/000446976. Epub 2016 Jun 20. Visc Med. 2016. PMID: 27722162 Free PMC article. Review.

7

Liver transplantation from HCV RNA-positive donors in the era of interferon-free HCV therapeutics: a re-examination of the situation.

Willuweit K, Canbay A, Gerken G, Timm J, Paul A, Treckmann J, Herzer K. Willuweit K, et al. Among authors: herzer k. Minerva Gastroenterol Dietol. 2017 Mar;63(1):55-61. doi: 10.23736/S1121-421X.16.02347-3. Epub 2016 Nov 8. Minerva Gastroenterol Dietol. 2017. PMID: 27824245 Review.

8

Immunosuppression with mTOR inhibitors prevents the development of donor-specific antibodies after liver transplant.

Willuweit K, Heinold A, Rashidi-Alavijeh J, Heinemann FM, Horn PA, Paul A, Gerken G, Herzer K. Willuweit K, et al. Among authors: herzer k. Clin Transplant. 2017 Jun;31(6). doi: 10.1111/ctr.12974. Epub 2017 Apr 16. Clin Transplant. 2017. PMID: 28345271

9

Expression of Fibrogenic Markers in Tumor and Tumor-Surrounding Tissue at Time of Transplantation Correlates with Recurrence of Hepatocellular Carcinoma in Patients Undergoing Liver Transplantation.

Kocabayoglu P, Piras-Straub K, Gerken G, Paul A, Herzer K. Kocabayoglu P, et al. Among authors: herzer k. Ann Transplant. 2017 Jul 21;22:446-454. doi: 10.12659/aot.903497. Ann Transplant. 2017. PMID: 28729525 Free article.

10

[Pulmonary affection in advanced liver disease - hepatepulonary syndrome and portopulmonary hypertension].

Herzer K, Post F, Canbay A, Gerken G. Herzer K, et al. Med Klin (Munich). 2010 Dec;105(12):916-23. doi: 10.1007/s00063-010-1157-9. Epub 2011 Jan 16. Med Klin (Munich). 2010. PMID: 21240591 Review. German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

111 results

Search Page

Filters